尿路上皮がん診断薬の世界市場：膀胱がんの増加が市場を牽引

当レポートでは、世界の尿路上皮がん診断薬市場について調査しており、市場概要、市場分析、競合分析など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 市場範囲/分類法
• 市場の定義/範囲/制限
• 包含と除外

第3章 主要な市場動向

• 市場に影響を与える主要な動向
• 製品イノベーション・開発動向

第4章 主な成功要因

• 製品採用・利用分析
• 製品のUSP/機能
• 最近の製品承認と発売
• PESTLE分析
• ポーターの分析
• 規制シナリオ
• バリューチェーン分析

第5章 市場の背景

• マクロ経済要因
  • 世界のGDP成長の展望
  • 世界の医療の展望
  • 世界の臨床診断市場の展望
• 予測要因－関連性と影響
  • 技術の進歩
  • 合併と買収
  • 主要企業の実績的成長
  • 市場の統合活動
  • 地域全体での尿路上皮がん診断薬の利用可能性
  • 製品およびサービスのコスト
  • 製品の採用
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会分析

第6章 COVID-19の危機－影響評価

• COVID-19と影響分析
  • 製品別
  • 検査別
  • エンドユーザー別
  • 地域別
• 市場シナリオ（2023年）

第7章 世界市場の需要（金額または規模、100万米ドル）の分析と予測

• 過去の市場分析
• 現在および将来の市場予測
  • 前年比成長動向分析

第8章 世界市場の分析と予測：製品別

• イントロダクション/主な調査結果
• 過去の市場分析：製品別
• 現在および将来の市場分析と予測：製品別
  • 試薬とキット
  • 機器
• 市場魅力度分析：製品別

第9章 世界市場の分析と予測：検査別

• イントロダクション/主な調査結果
• 過去の市場分析：検査別
• 現在および将来の市場分析と予測：検査別
  • 尿検査
  • 分子診断検査
  • バイオマーカー検査
  • 画像検査
  • 細胞診
  • 尿管鏡検査
• 市場魅力分析：検査別

第10章 世界市場の分析と予測：エンドユーザー別

• イントロダクション/主な調査結果
• 過去の市場分析：エンドユーザー別
• 現在および将来の市場分析と予測：エンドユーザー別
  • 病院
  • 診断ラボ
  • 研究機関・学術機関
  • 臨床研究機関
• 市場魅力分析：エンドユーザー別

第11章 世界市場の分析と予測：地域別

• イントロダクション
• 過去の市場分析：地域別
• 現在および将来の市場分析と予測：地域別
  • 北米
  • ラテンアメリカ
  • 欧州
  • 南アジア
  • 東アジア
  • オセアニア
  • 中東・アフリカ
• 市場魅力度分析：地域別

第12章 北米市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 欧州市場の分析と予測

第15章 南アジア市場の分析と予測

第16章 東アジア市場の分析と予測

第17章 オセアニア市場の分析と予測

第18章 中東およびアフリカ市場の分析と予測

第19章 市場構造分析

• 市場分析：企業層別
• 主要企業の市場シェア分析
• 市場プレゼンス分析

第20章 競合分析

• 競合ダッシュボード
• ブランディングとプロモーション戦略
• 主要開発分析
• 競合の詳細
  • GE Healthcare
  • Roche Holding
  • Illumina
  • IDL Biotech
  • Agilent Technologies
  • Olympus Corporation
  • Philips Healthcare
  • Abbott Molecular
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.（Qiagen N.V.）
  • Danaher Corporation（Cepheid）

第21章 使用される仮定と頭字語

第22章 調査手法

List of Tables

• Table 01: Global Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 02: Global Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033, by Test
• Table 03: Global Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 04: Global Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033, by Region
• Table 05: North America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 06: North America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 07: North America Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 08: North America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 09: Latin America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 10: Latin America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 11: Latin America Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 12: Latin America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 13: Europe Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 14: Europe Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 15: Europe Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 16: Europe Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 17: East Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 18: East Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 19: East Asia Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 20: East Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 21: South Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 22: South Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 23: South Asia Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 24: South Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 25: Oceania Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 26: Oceania Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 27: Oceania Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 28: Oceania Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
• Table 29: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
• Table 30: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
• Table 31: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Analysis 2015-2022 and Forecast 2023-2033by Test
• Table 32: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User

List of Figures

• Figure 01: Global Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 02: Global Urothelial Carcinoma Diagnostics Market Forecast & Y-o-Y Growth, 2023-2033
• Figure 03: Global Urothelial Carcinoma Diagnostics Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
• Figure 04: Global Urothelial Carcinoma Diagnostics Market Value Share (%) Analysis 2023 and 2033, by Product
• Figure 05: Global Urothelial Carcinoma Diagnostics Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
• Figure 06: Global Urothelial Carcinoma Diagnostics Market Attractiveness Analysis 2023-2033, by Product
• Figure 07: Global Urothelial Carcinoma Diagnostics Market Value Share (%) Analysis 2023 and 2033, by Test
• Figure 08: Global Urothelial Carcinoma Diagnostics Market Y-o-Y Growth (%) Analysis 2022-2033, by Test
• Figure 09: Global Urothelial Carcinoma Diagnostics Market Attractiveness Analysis 2023-2033, by Test
• Figure 10: Global Urothelial Carcinoma Diagnostics Market Value Share (%) Analysis 2023 and 2033, by End User
• Figure 11: Global Urothelial Carcinoma Diagnostics Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
• Figure 12: Global Urothelial Carcinoma Diagnostics Market Attractiveness Analysis 2023-2033, by End User
• Figure 13: Global Urothelial Carcinoma Diagnostics Market Value Share (%) Analysis 2023 and 2033, by Region
• Figure 14: Global Urothelial Carcinoma Diagnostics Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
• Figure 15: Global Urothelial Carcinoma Diagnostics Market Attractiveness Analysis 2023-2033, by Region
• Figure 16: North America Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 17: North America Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 18: North America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 19: North America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 20: North America Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 21: North America Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 22: North America Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 23: North America Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 24: North America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 25: North America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 26: North America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 27: North America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 28: U.S. Market Value Proportion Analysis, 2022
• Figure 29: U.S. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 30: U.S. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 31: U.S. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 32: Global Vs. U.S. Growth Comparison
• Figure 33: Canada Market Value Proportion Analysis, 2022
• Figure 34: Canada Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 35: Canada Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 36: Canada Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 37: Global Vs. Canada. Growth Comparison
• Figure 38: Latin America Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 39: Latin America Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 40: Latin America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 41: Latin America Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 42: Latin America Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 43: Latin America Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 44: Latin America Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 45: Latin America Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 46: Latin America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 47: Latin America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 48: Latin America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 49: Latin America Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 50: Mexico Market Value Proportion Analysis, 2022
• Figure 51: Mexico Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 52: Mexico Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 53: Mexico Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 54: Global Vs Mexico Growth Comparison
• Figure 55: Brazil Market Value Proportion Analysis, 2022
• Figure 56: Brazil Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 57: Brazil Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 58: Brazil Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 59: Global Vs. Brazil. Growth Comparison
• Figure 60: Argentina Market Value Proportion Analysis, 2022
• Figure 61: Argentina Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 62: Argentina Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 63: Argentina Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 64: Global Vs Argentina Growth Comparison
• Figure 65: Europe Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 66: Europe Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 67: Europe Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 68: Europe Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 69: Europe Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 70: Europe Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 71: Europe Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 72: Europe Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 73: Europe Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 74: Europe Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 75: Europe Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 76: Europe Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 77: U.K. Market Value Proportion Analysis, 2022
• Figure 78: U.K. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 79: U.K. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 80: U.K. Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 81: Global Vs. U.K. Growth Comparison
• Figure 82: Germany Market Value Proportion Analysis, 2022
• Figure 83: Germany Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 84: Germany Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 85: Germany Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 86: Global Vs. Germany Growth Comparison
• Figure 87: Italy Market Value Proportion Analysis, 2022
• Figure 88: Italy Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 89: Italy Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 90: Italy Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 91: Global Vs. Italy Growth Comparison
• Figure 92: France Market Value Proportion Analysis, 2022
• Figure 93: France Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 94: France Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 95: France Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 96: Global Vs France Growth Comparison
• Figure 97: Spain Market Value Proportion Analysis, 2022
• Figure 98: Spain Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 99: Spain Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 100: Spain Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 101: Global Vs Spain Growth Comparison
• Figure 102: Russia Market Value Proportion Analysis, 2022
• Figure 103: Russia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 104: Russia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 105: Russia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 106: Global Vs Russia Growth Comparison
• Figure 107: BENELUX Market Value Proportion Analysis, 2022
• Figure 108: BENELUX Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 109: BENELUX Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 110: BENELUX Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 111: Global Vs BENELUX Growth Comparison
• Figure 107: Nordic Countries Market Value Proportion Analysis, 2022
• Figure 108: Nordic Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 109: Nordic Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 110: Nordic Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 111: Global Vs Nordic Countries Growth Comparison
• Figure 112: East Asia Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 113: East Asia Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 114: East Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 115: East Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 116: East Asia Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 117: East Asia Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 118: East Asia Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 119: East Asia Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 120: East Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 121: East Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 122: East Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 123: East Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 124: China Market Value Proportion Analysis, 2022
• Figure 125: China Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 126: China Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 127: China Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 128: Global Vs. China Growth Comparison
• Figure 129: Japan Market Value Proportion Analysis, 2022
• Figure 130: Japan Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 131: Japan Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 132: Japan Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 133: Global Vs. Japan Growth Comparison
• Figure 134: South Korea Market Value Proportion Analysis, 2022
• Figure 135: South Korea Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 136: South Korea Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 137: South Korea Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 138: Global Vs South Korea Growth Comparison
• Figure 139: South Asia Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 140: South Asia Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 141: South Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 142: South Asia Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 143: South Asia Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 144: South Asia Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 145: South Asia Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 146: South Asia Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 147: South Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 148: South Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 149: South Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 150: South Asia Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 151: India Market Value Proportion Analysis, 2022
• Figure 152: India Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 153: India Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 154: India Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 155: Global Vs. India Growth Comparison
• Figure 156: Indonesia Market Value Proportion Analysis, 2022
• Figure 157: Indonesia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 158: Indonesia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 159: Indonesia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 160: Global Vs. Indonesia Growth Comparison
• Figure 161: Malaysia Market Value Proportion Analysis, 2022
• Figure 162: Malaysia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 163: Malaysia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 164: Malaysia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 165: Global Vs. Malaysia Growth Comparison
• Figure 166: Thailand Market Value Proportion Analysis, 2022
• Figure 167: Thailand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 168: Thailand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 169: Thailand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 170: Global Vs. Thailand Growth Comparison
• Figure 171: Oceania Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E & 2033F
• Figure 172: Oceania Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 173: Oceania Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 174: Oceania Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 175: Oceania Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 176: Oceania Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 177: Oceania Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 178: Oceania Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 179: Oceania Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 180: Oceania Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 181: Oceania Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 182: Oceania Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 183: Australia Market Value Proportion Analysis, 2022
• Figure 184: Australia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 185: Australia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 186: Australia Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 187: Global Vs. Australia Growth Comparison
• Figure 188: New Zealand Market Value Proportion Analysis, 2022
• Figure 189: New Zealand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 & 2033
• Figure 190: New Zealand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 & 2033
• Figure 191: New Zealand Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 & 2033
• Figure 192: Global Vs New Zealand Growth Comparison
• Figure 193: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Size (US$ Mn) Analysis, 2023E and 2033F
• Figure 194: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Y-o-Y Analysis, 2023-2033
• Figure 195: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Analysis, 2015-2022
• Figure 196: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value (US$ Mn) Forecast, 2023-2033
• Figure 197: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value Share, by Product (2023 E)
• Figure 198: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value Share, by Test (2023 E)
• Figure 199: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value Share, by End User (2023 E)
• Figure 200: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Value Share, by Country (2023 E)
• Figure 201: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Product, 2023-2033
• Figure 202: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Test, 2023-2033
• Figure 203: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by End User, 2023-2033
• Figure 204: Middle East and Africa (MEA) Urothelial Carcinoma Diagnostics Market Attractiveness Analysis by Country, 2023-2033
• Figure 205: GCC Countries Market Value Proportion Analysis, 2022
• Figure 206: GCC Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 and 2033
• Figure 207: GCC Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 and 2033
• Figure 208: GCC Countries Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 and 2033
• Figure 209: Global Vs GCC Countries Growth Comparison
• Figure 210: Turkiye Market Value Proportion Analysis, 2022
• Figure 211: Turkiye Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 and 2033
• Figure 212: Turkiye Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 and 2033
• Figure 213: Turkiye Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 and 2033
• Figure 214: Global Vs. Turkiye Growth Comparison
• Figure 215: South Africa Market Value Proportion Analysis, 2022
• Figure 216: South Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 and 2033
• Figure 217: South Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 and 2033
• Figure 218: South Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 and 2033
• Figure 219: Global Vs. South Africa Growth Comparison
• Figure 220: North Africa Market Value Proportion Analysis, 2022
• Figure 221: North Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Product, 2022 and 2033
• Figure 222: North Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by Test, 2022 and 2033
• Figure 223: North Africa Urothelial Carcinoma Diagnostics Market Share Analysis (%) by End User, 2022 and 2033
• Figure 224: Global Vs North Africa Growth Comparison

Urothelial Carcinoma Diagnostics Market: Scope of the Report

The latest publication by Persistence Market Research on the global urothelial carcinoma diagnostics market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for urothelial carcinoma diagnostic products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the urothelial carcinoma diagnostics market. Shareholders in the urothelial carcinoma diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the urothelial carcinoma diagnostics market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the urothelial carcinoma diagnostics market offers information divided into four important segments - product, test type, end-user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Reagent and Kits

Instruments

Test

Urinalysis Test

Molecular Diagnostic Test

Biomarker Test

Immuno-Histochemical Assay Test

In Situ Hybridization Test

Biopsy

Cell-Based Test

Imaging Test

Cytoscopy

Ureteroscopy

End-User

Hospitals

Diagnostic Laboratories

Research and Academic Institutes

Clinical Research Organizations

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for urothelial carcinoma diagnostics over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the urothelial carcinoma diagnostics market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the urothelial carcinoma diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the urothelial carcinoma diagnostics market are more accurate and reliable.

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Recent Product Approval and Launches
• 4.4. PESTLE Analysis
• 4.5. Porter's Analysis
• 4.6. Regulatory Scenario
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Clinical Diagnostics Market Outlook
• 5.2. Forecast Factors - Relevance and Impact
  • 5.2.1. Technological Advancements
  • 5.2.2. Mergers and Acquisitions
  • 5.2.3. Key Players Historical Growth
  • 5.2.4. Market Consolidation Activities
  • 5.2.5. Availability of Urothelial Carcinoma Diagnostics across Regions
  • 5.2.6. Cost of Product and Services
  • 5.2.7. Product Adoption
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Test
  • 6.1.3. By End User
  • 6.1.4. By Region
• 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2022
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
  • 8.3.1. Reagent and Kits
  • 8.3.2. Instruments
• 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Test

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Test, 2015-2022
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test, 2023-2033
  • 9.3.1. Urinalysis Test
  • 9.3.2. Molecular Diagnostic Test
  • 9.3.3. Biomarker Test
    • 9.3.3.1. Immuno-Histochemical Assay Test
    • 9.3.3.2. In Situ Hybridization Test
    • 9.3.3.3. Biopsy
    • 9.3.3.4. Cell-Based Test
  • 9.3.4. Imaging Test
  • 9.3.5. Cytoscopy
  • 9.3.6. Ureteroscopy
• 9.4. Market Attractiveness Analysis By Test

10. Global Market Analysis 2015-2022 and Forecast 2023-2033, by End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2022
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023-2033
  • 10.3.1. Hospitals
  • 10.3.2. Diagnostic Laboratories
  • 10.3.3. Research and Academic Institutes
  • 10.3.4. Clinical Research Organizations
• 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. South Asia
  • 11.3.5. East Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2015-2022 and Forecast 2023-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Test
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Test
  • 12.4.4. By End User
• 12.5. Country Level Analysis and Forecast
  • 12.5.1. U.S. Market Analysis
    • 12.5.1.1. Introduction
    • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.5.1.2.1. By Product
      • 12.5.1.2.2. By Test
      • 12.5.1.2.3. By End User
  • 12.5.2. Canada Market Analysis
    • 12.5.2.1. Introduction
    • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.5.2.2.1. By Product
      • 12.5.2.2.2. By Test
      • 12.5.2.2.3. By End User
• 12.6. Market Trends
• 12.7. Key Market Participants - Intensity Mapping
• 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Market Analysis 2015-2022 and Forecast 2023-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Mexico
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Test
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Test
  • 13.4.4. By End User
• 13.5. Country Level Analysis and Forecast
  • 13.5.1. Brazil Market Analysis
    • 13.5.1.1. Introduction
    • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.1.2.1. By Product
      • 13.5.1.2.2. By Test
      • 13.5.1.2.3. By End User
  • 13.5.2. Mexico Market Analysis
    • 13.5.2.1. Introduction
    • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.2.2.1. By Product
      • 13.5.2.2.2. By Test
      • 13.5.2.2.3. By End User
  • 13.5.3. Argentina Market Analysis
    • 13.5.3.1. Introduction
    • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.3.2.1. By Product
      • 13.5.3.2.2. By Test
      • 13.5.3.2.3. By End User
• 13.6. Market Trends
• 13.7. Key Market Participants - Intensity Mapping
• 13.8. Drivers and Restraints - Impact Analysis

14. Europe Market Analysis 2015-2022 and Forecast 2023-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. France
    • 14.3.1.3. Italy
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. Russia
    • 14.3.1.7. BENELUX
    • 14.3.1.8. Nordic Countries
    • 14.3.1.9. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Test
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Test
  • 14.4.4. By End User
• 14.5. Country Level Analysis and Forecast
  • 14.5.1. Germany Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Product
      • 14.5.1.2.2. By Test
      • 14.5.1.2.3. By End User
  • 14.5.2. France Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Product
      • 14.5.2.2.2. By Test
      • 14.5.2.2.3. By End User
  • 14.5.3. Italy Market Analysis
    • 14.5.3.1. Introduction
    • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.3.2.1. By Product
      • 14.5.3.2.2. By Test
      • 14.5.3.2.3. By End User
  • 14.5.4. U.K. Market Analysis
    • 14.5.4.1. Introduction
    • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.4.2.1. By Product
      • 14.5.4.2.2. By Test
      • 14.5.4.2.3. By End User
  • 14.5.5. Spain Market Analysis
    • 14.5.5.1. Introduction
    • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.5.2.1. By Product
      • 14.5.5.2.2. By Test
      • 14.5.5.2.3. By End User
  • 14.5.6. Russia Market Analysis
    • 14.5.6.1. Introduction
    • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.6.2.1. By Product
      • 14.5.6.2.2. By Test
      • 14.5.6.2.3. By End User
  • 14.5.7. Nordic Countries Market Analysis
    • 14.5.7.1. Introduction
    • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.7.2.1. By Product
      • 14.5.7.2.2. By Test
      • 14.5.7.2.3. By End User
  • 14.5.8. BENELUX Market Analysis
    • 14.5.8.1. Introduction
    • 14.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.8.2.1. By Product
      • 14.5.8.2.2. By Test
      • 14.5.8.2.3. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Market Analysis 2015-2022 and Forecast 2023-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2015-2022
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Thailand
    • 15.3.1.3. Indonesia
    • 15.3.1.4. Malaysia
    • 15.3.1.5. Rest of South Asia
  • 15.3.2. By Product
  • 15.3.3. By Test
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Test
  • 15.4.4. By End User
• 15.5. Country Level Analysis and Forecast
  • 15.5.1. India Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Product
      • 15.5.1.2.2. By Test
      • 15.5.1.2.3. By End User
  • 15.5.2. Thailand Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Product
      • 15.5.2.2.2. By Test
      • 15.5.2.2.3. By End User
  • 15.5.3. Indonesia Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Product
      • 15.5.3.2.2. By Test
      • 15.5.3.2.3. By End User
  • 15.5.4. Malaysia Market Analysis
    • 15.5.4.1. Introduction
    • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.4.2.1. By Product
      • 15.5.4.2.2. By Test
      • 15.5.4.2.3. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. East Asia Market Analysis 2015-2022 and Forecast 2023-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product
  • 16.3.3. By Test
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Test
  • 16.4.4. By End User
• 16.5. Country Level Analysis and Forecast
  • 16.5.1. China Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product
      • 16.5.1.2.2. By Test
      • 16.5.1.2.3. By End User
  • 16.5.2. Japan Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product
      • 16.5.2.2.2. By Test
      • 16.5.2.2.3. By End User
  • 16.5.3. South Korea Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Product
      • 16.5.3.2.2. By Test
      • 16.5.3.2.3. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Market Analysis 2015-2022 and Forecast 2023-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Test
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Test
  • 17.4.4. By End User
• 17.5. Country Level Analysis and Forecast
  • 17.5.1. Australia Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product
      • 17.5.1.2.2. By Test
      • 17.5.1.2.3. By End User
  • 17.5.2. New Zealand Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product
      • 17.5.2.2.2. By Test
      • 17.5.2.2.3. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2015-2022 and Forecast 2023-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkiye
    • 18.3.1.3. Northern Africa
    • 18.3.1.4. South Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Test
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Test
  • 18.4.4. By End User
• 18.5. Country Level Analysis and Forecast
  • 18.5.1. GCC Countries Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product
      • 18.5.1.2.2. By Test
      • 18.5.1.2.3. By End User
  • 18.5.2. Turkiye Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product
      • 18.5.2.2.2. By Test
      • 18.5.2.2.3. By End User
  • 18.5.3. Northern Africa Market Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Product
      • 18.5.3.2.2. By Test
      • 18.5.3.2.3. By End User
  • 18.5.4. South Africa Market Analysis
    • 18.5.4.1. Introduction
    • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.4.2.1. By Product
      • 18.5.4.2.2. By Test
      • 18.5.4.2.3. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Branding and Promotional Strategies
• 20.3. Key Development Analysis
• 20.4. Competition Deep Dive
  • 20.4.1. GE Healthcare
    • 20.4.1.1. Overview
    • 20.4.1.2. Product Portfolio
    • 20.4.1.3. Key Financials
    • 20.4.1.4. SWOT Analysis
    • 20.4.1.5. Sales Footprint
    • 20.4.1.6. Strategy Overview
      • 20.4.1.6.1. Marketing Strategy
      • 20.4.1.6.2. Product Strategy
      • 20.4.1.6.3. Channel Strategy
  • 20.4.2. Roche Holding
    • 20.4.2.1. Overview
    • 20.4.2.2. Product Portfolio
    • 20.4.2.3. Key Financials
    • 20.4.2.4. SWOT Analysis
    • 20.4.2.5. Sales Footprint
    • 20.4.2.6. Strategy Overview
      • 20.4.2.6.1. Marketing Strategy
      • 20.4.2.6.2. Product Strategy
      • 20.4.2.6.3. Channel Strategy
  • 20.4.3. Illumina
    • 20.4.3.1. Overview
    • 20.4.3.2. Product Portfolio
    • 20.4.3.3. Key Financials
    • 20.4.3.4. SWOT Analysis
    • 20.4.3.5. Sales Footprint
    • 20.4.3.6. Strategy Overview
      • 20.4.3.6.1. Marketing Strategy
      • 20.4.3.6.2. Product Strategy
      • 20.4.3.6.3. Channel Strategy
  • 20.4.4. IDL Biotech
    • 20.4.4.1. Overview
    • 20.4.4.2. Product Portfolio
    • 20.4.4.3. Key Financials
    • 20.4.4.4. SWOT Analysis
    • 20.4.4.5. Sales Footprint
    • 20.4.4.6. Strategy Overview
      • 20.4.4.6.1. Marketing Strategy
      • 20.4.4.6.2. Product Strategy
      • 20.4.4.6.3. Channel Strategy
  • 20.4.5. Agilent Technologies
    • 20.4.5.1. Overview
    • 20.4.5.2. Product Portfolio
    • 20.4.5.3. Key Financials
    • 20.4.5.4. SWOT Analysis
    • 20.4.5.5. Sales Footprint
    • 20.4.5.6. Strategy Overview
      • 20.4.5.6.1. Marketing Strategy
      • 20.4.5.6.2. Product Strategy
      • 20.4.5.6.3. Channel Strategy
  • 20.4.6. Olympus Corporation
    • 20.4.6.1. Overview
    • 20.4.6.2. Product Portfolio
    • 20.4.6.3. Key Financials
    • 20.4.6.4. SWOT Analysis
    • 20.4.6.5. Sales Footprint
    • 20.4.6.6. Strategy Overview
      • 20.4.6.6.1. Marketing Strategy
      • 20.4.6.6.2. Product Strategy
      • 20.4.6.6.3. Channel Strategy
  • 20.4.7. Philips Healthcare
    • 20.4.7.1. Overview
    • 20.4.7.2. Product Portfolio
    • 20.4.7.3. Key Financials
    • 20.4.7.4. SWOT Analysis
    • 20.4.7.5. Sales Footprint
    • 20.4.7.6. Strategy Overview
      • 20.4.7.6.1. Marketing Strategy
      • 20.4.7.6.2. Product Strategy
      • 20.4.7.6.3. Channel Strategy
  • 20.4.8. Abbott Molecular
    • 20.4.8.1. Overview
    • 20.4.8.2. Product Portfolio
    • 20.4.8.3. Key Financials
    • 20.4.8.4. SWOT Analysis
    • 20.4.8.5. Sales Footprint
    • 20.4.8.6. Strategy Overview
      • 20.4.8.6.1. Marketing Strategy
      • 20.4.8.6.2. Product Strategy
      • 20.4.8.6.3. Channel Strategy
  • 20.4.9. Bio-Rad Laboratories, Inc.
    • 20.4.9.1. Overview
    • 20.4.9.2. Product Portfolio
    • 20.4.9.3. Key Financials
    • 20.4.9.4. SWOT Analysis
    • 20.4.9.5. Sales Footprint
    • 20.4.9.6. Strategy Overview
      • 20.4.9.6.1. Marketing Strategy
      • 20.4.9.6.2. Product Strategy
      • 20.4.9.6.3. Channel Strategy
  • 20.4.10. Thermo Fisher Scientific, Inc. (Qiagen N.V.)
    • 20.4.10.1. Overview
    • 20.4.10.2. Product Portfolio
    • 20.4.10.3. Key Financials
    • 20.4.10.4. SWOT Analysis
    • 20.4.10.5. Sales Footprint
    • 20.4.10.6. Strategy Overview
      • 20.4.10.6.1. Marketing Strategy
      • 20.4.10.6.2. Product Strategy
      • 20.4.10.6.3. Channel Strategy
  • 20.4.11. Danaher Corporation (Cepheid)
    • 20.4.11.1. Overview
    • 20.4.11.2. Product Portfolio
    • 20.4.11.3. Key Financials
    • 20.4.11.4. SWOT Analysis
    • 20.4.11.5. Sales Footprint
    • 20.4.11.6. Strategy Overview
      • 20.4.11.6.1. Marketing Strategy
      • 20.4.11.6.2. Product Strategy
      • 20.4.11.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology